Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Background The incidence of malignant mesothelioma in Germany is about 20 cases per
million persons per year. Its association with asbestos exposure, usually occupational, has …

Background The effects of extra-pleural pneumonectomy (EPP) on survival and quality of life
in patients with malignant pleural mesothelioma have, to our knowledge, not been assessed …

Background This comprehensive meta-analysis was conducted to answer the question as to
which procedure, pleurectomy decortication (P/D) or extrapleural pneumonectomy (EPP) is …

BACKGROUND: Malignant pleural mesothelioma is a locally aggressive tumor that is
usually fatal. Extrapleural pneumonectomy (EPP) followed by hemithoracic irradiation has …

Introduction Most studies describing the natural history and prognostic factors for malignant
pleural mesothelioma antedate accurate pathologic diagnosis, staging by computed …

The first British Thoracic Society (BTS) state-ment on mesothelioma was published in 2001
by a Working Party of the Standards of Care Committee of the BTS1 in response to a request …

Surgical intervention plays an important role in the diagnosis, staging, and treatment of
malignant pleural mesothelioma (MPM) and can be applied with curative or palliative intent …

Introduction: The primary objective of the present systematic review was to evaluate the
safety and efficacy of extrapleural pneumonectomy (EPP) for patients with malignant pleural …

Management of malignant pleural mesothelioma (MPM) remains a clinical challenge and
the incidence of the disease will continue to increase worldwide. Several aspects of …